Researchers at Boston Children’s Hospital have developed a technology to non-invasively trigger the release of nerve-blocking agents, helping to provide targeted pain-relief to patients as an alternative to addictive opioids.
The team’s work was published yesterday in Nature Biomedical Engineering.
Get the full story at our sister site, Drug Delivery Business News.
The post Liposomes triggered by ultrasound enable targeted pain-relief appeared first on MassDevice.